Federated Investors »

Rapport Therapeutics shares owned by Federated Investors

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Federated Investors from 13F filings

Historical chart of Federated Investors investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Federated Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Federated Investors

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.7k 55 30.35

More positions owned by Federated Investors

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Amazon (AMZN)
Abbvie (ABBV)
Broadcom (AVGO)
Philip Morris International (PM)
Viking Holdings Ord Shs (VIK)
PNC Financial Services (PNC)
Us Bancorp Del Com New (USB)
Amgen (AMGN)
Exxon Mobil Corporation (XOM)
Prologis (PLD)
Truist Financial Corp equities (TFC)

View all positions for Federated Investors

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
BlackRock
Sofinnova Ventures
Vanguard Group
Johnson & Johnson
Baker Bros. Advisors
Vestal Point Capital
Polar Capital Holdings
Trv Gp Vi
Ubs Global Asset Management Americas

View all funds holding Rapport Therapeutics